DGAP-News: MPH Mittelstaendische Pharma Holding AG

DGAP-News: MPH Mittelständische Pharma Holding AG: Positive business performance in the first 9 months of 2015

DGAP-News: MPH Mittelständische Pharma Holding AG / Key word(s): 9-month figures/Quarter Results MPH Mittelständische Pharma Holding AG: Positive business performance in the first 9 months of 2015

30.11.2015 / 08:00 The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

MPH Mittelständische Pharma Holding AG: Positive business performance in the first 9 months of 2015

In the first 9 months of 2015 MPH Group achieved sales to the amount of 178.6 million Euro (previous year's period: 163.8 million Euro). The profit for the period totalled 4.0 million Euro. The affiliated companies of MPH AG could further expand their position in the healthcare market.

The performance of the shareholdings was very positive. The listed investments in HAEMATO, M1 and CR Capital valued at 133.5 million Euro as of 30.09.2015. Compared to the previous quarter the entire intrinsic value of the MPH AG increased by 16 % and totalled 134.6 million Euro as of 30.09.2015. This corresponds to 3.14 Euro per share.

We are very pleased with the performance of our investments. This argues for our valuable investment strategy and gives us confidence for the whole year 2015", say Patrick Brenske and Dr Christian Pahl, Members of the Management Board of MPH AG about the 9-months figures.

About MPH Mittelständische Pharma Holding AG: The Berlin based MPH Mittelständische Pharma Holding AG invests mainly in companies acting in the healthcare market. The shareholding HAEMATO AG contributes to cost reductions in the healthcare systems with medicines on the basis of patent-free and patent-protected active substances for therapies of chronic diseases. M1 Beauty AG offers patient-individual services, aesthetic surgeries and medical treatments.

The MPH Mittelständische Pharma Holding AG is listed in the Entry Standard (Open Market) on the Frankfurt stock exchange.

Key figures for the share of MPH Mittelständische Pharma Holding AG: Subscribed capital: EUR 42,813,842 Listed shares: ordinary shares ISIN: DE000A0L1H32 WKN: A0L1H3 Stock symbol: 93M

Contact: Frau Linda Reichelt MPH Mittelständische Pharma Holding AG Grünauer Straße 5 D-12557 Berlin

Phone: +49 (0) 30 897308660 Fax: +49 (0) 30 897308669 E-Mail: ir@mph-ag.de Web: www.mph-ag.de

---------------------------------------------------------------------------

30.11.2015 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------

Language: English Company: MPH Mittelständische Pharma Holding AG Grünauer Straße 5 12557 Berlin Germany Phone: 030 / 897 308 660 Fax: 030 / 897 308 669 E-mail: info@mph-ag.de Internet: www.mph-ag.de ISIN: DE000A0L1H32 WKN: A0L1H3 Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Stuttgart; Open Market (Entry Standard) in Frankfurt End of News DGAP News Service ---------------------------------------------------------------------------

418531 30.11.2015